Search

06/01/2026 Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort
León-Mengíbar, J, Malagón, MM, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro, E, Fernández, E, Caixàs, A, Hernández, M, Lopez-Cano, C, Gordon, A, Guzman-Ruiz, R, Cusi, K, Lecube, A. Association of estimated liver fibrosis with carotid but not femoral atherosclerotic burden: the ILERVAS cohort. Frontiers in Endocrinology. 2026; 16DOI:10.3389/fendo.2025.1651689. PMID:41567808. IF:4.600(Q1/3D).
01/01/2026 In women with pre-existing diabetes, the contribution to pregnancy outcomes of gestational weight gain as defined by IOM guidelines, differs when adjustment for gestational age is used
Xie, XL, Liu, JM, López, A, Garcia-Patterson, A, Adelantado, JM, López, E, Corcoy, R. In women with pre-existing diabetes, the contribution to pregnancy outcomes of gestational weight gain as defined by IOM guidelines, differs when adjustment for gestational age is used. ACTA DIABETOLOGICA. 2026; 63(1)DOI:10.1007/s00592-025-02587-z. PMID:41055719. IF:2.900(Q3/6D).
01/01/2026 Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data
Navarro-González, JF, de Isla, LP, Molina, GC, Brito-Sanfiel, MA, Galindo, DEB, Olmedo, LAC, Mauricio, D, Povedano, ST, Barro, JAB, Almanza, MR, Sánchez, JJA, Mutiozabal, MS, Pimentel, B, Domínguez, AP, Arias-Cabrales, C, Fanjul, V, Blanco-Carrasco, AJ, Torres, JFM. Predicting Chronic Kidney Disease in Type 2 Diabetes Using Natural Language Processing on Healthcare Data. Kidney Diseases. 2026; 12(1)DOI:10.1159/000547604. PMID:41510180. IF:3.100(Q1/3D).
01/01/2026 Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study
Ritzel, R, Davies, MJ, Hao, LC, Ji, LN, Lintu, MK, Mabunay, A, Mauricio, D, Bailey, T. Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T Study. Diabetes Therapy. 2026; 17(1)DOI:10.1007/s13300-025-01798-5. PMID:41269514. IF:2.600(Q3/6D).